To determine whether partial inhibition of LLO assembly by long-term preconditioning with low-dose TM affects CSC conversion, we pretreated HA-low Has2+Neo cancer cells for 8 days with TM at varying concentrations and evaluated their effects on CSC-like properties. Here, HAS2 is linked to cancer.